Earnings Summary

West Pharmaceutical Services Inc’s revenue fell -2.96% since last year same period to $695.4Mn in the Q1 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated -5% fall in its revenue since last 3-months.

West Pharmaceutical Services Inc’s net profit fell -17.64% since last year same period to $115.3Mn in the Q1 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated -15.84% fall in its net profits since last 3-months.

West Pharmaceutical Services Inc’s net profit margin fell -15.13% since last year same period to 16.58% in the Q1 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated -11.41% fall in its net profit margins since last 3-months.

West Pharmaceutical Services Inc’s price-to-earnings ratio after this Q1 2024 earnings stands at 41.66.

West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current quarter stand at 1.74 - a 38.1% jump from last quarter’s estimates.

West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current year stand at 1.74.

West Pharmaceutical Services Inc’s earning per share (EPS) fell -21.21% since last year same period to 1.56 in the Q1 2024. This indicates that the West Pharmaceutical Services Inc has generated -21.21% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. West Pharmaceutical Services Inc’s return on assets (ROA) stands at 0.11.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. West Pharmaceutical Services Inc’s return on equity (ROE) stands at 0.21.

West Pharmaceutical Services Inc declared 0.2 dividend per share during the earnings announcement for Q1 2024.